Combination of docetaxel, trastuzumab and pertuzumab or treatment with trastuzumab-emtansine for metastatic salivary duct carcinoma
Publication date: Available online 30 June 2017 Source:Oral Oncology Author(s): Wim van Boxtel, Eline Boon, Willem L.J. Weijs, Frank J.A. van den Hoogen, Uta E. Flucke, Carla M.L. van Herpen
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου